美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Metsera Inc.

70.50

0.0000

成交量：- -

成交額：- -

市值：74.29億

市盈率：-11.96

高：70.50

開：70.50

低：70.50

收：70.50

52周最高：83.86

52周最低：12.30

股本：1.05億

流通股本：6,451.37萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-5.8924

每股收益(LYR):-14.4907

淨資產收益率：-134.66%

總資產收益率：-38.77%

市淨率：22.03

市盈率(LYR):-4.87

資料載入中...

總覽公司新聞資訊公告

輝瑞收購Metsera：交易經過與未來減重市場格局分析

分析-諾和諾德首席執行官在肥胖症交易中釋放出新的風險偏好信號

GLP-1「三國殺」開局？輝瑞百億鎖定Metsera，諾和諾德中國出招應戰

医药经济报

輝瑞三季淨賺49億美元，100億收購Metsera佈局減重市場

ITBEAR科技资讯

FTC出手，諾和諾德出局：輝瑞100億美元收購Metsera後股價雙雙下跌

MedTrend医趋势

三季淨賺49億美元！醫藥巨頭輝瑞，100億美元收購Metsera

11月11日隔夜要聞：美股收高小鵬汽車大漲蘋果將推遲下一代iPhoneAir 輝瑞贏得Metsera競購戰

环球市场播报

醫療保健市場動態綜述

背景資料-隨着競爭白熱化，減肥藥開發商排隊開發利潤豐厚的市場

輝瑞首席執行官：預計公司將為Metsera支付全部或有價值權利款項。

Metsera Inc. - 在某些情況下公司需支付的終止費用增加至2.65億美元 - SEC文件

輝瑞豪擲百億美元拿下Metsera，諾和諾德放棄加碼

背景資料-過去十年涉及美國製藥商和生物技術公司的重大交易

BUZZ-輝瑞以 100 億美元收購美特斯邦威，競購戰結束，美特斯邦威暴跌

近期交易合作|藥捷安康臨床前小分子出海，輝瑞截胡諾和諾德收購Metsera

Metsera已接受輝瑞100億美元的收購要約

老虎资讯综合

諾和諾德宣佈不再提高對Metsera的收購報價

巨頭加價159%，搶購減肥藥公司

21世纪经济报道

Metsera：接受輝瑞100億美元收購要約

南方财经网

諾和諾德：鑑於公司對財務紀律和股東價值的承諾，不會提高收購Metsera的報價。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MTSR/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"MTSR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTSR\",,,,,undefined,":{"symbol":"MTSR","market":"US","secType":"STK","nameCN":"Metsera Inc.","latestPrice":70.5,"timestamp":1774641600000,"preClose":70.5,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":64513712,"shares":105376189,"eps":-5.892395,"marketStatus":"休市中","change":0,"latestTime":"03-27 16:00:00 EDT","open":70.5,"high":70.5,"low":70.5,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.892395,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"listingDate":1738299600000,"exchange":"NASDAQ","adjPreClose":70.5,"volumeRatio":0,"impliedVol":0.3139,"impliedVolPercentile":0.2016},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTSR\",,,,,undefined,":{"symbol":"MTSR","floatShares":64513712,"roa":"-38.77%","roe":"-134.66%","lyrEps":-14.490661,"shares":105376189,"dividePrice":0,"high":70.5,"amplitude":0,"preClose":70.5,"low":70.5,"week52Low":12.3,"pbRate":"22.03","week52High":83.8599,"institutionHeld":0,"latestPrice":70.5,"eps":-5.892395,"divideRate":0,"volume":0,"delay":0,"ttmEps":-5.892395,"open":70.5,"prevYearClose":70.5,"prevWeekClose":70.5,"prevMonthClose":70.5,"prevQuarterClose":70.5,"fiveDayClose":70.5,"twentyDayClose":70.5,"sixtyDayClose":70.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MTSR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"MTSR","reason":null,"defaultRemindTime":1763130600000,"announcedDate":"2025-11-12","type":"delisting","dateTimestamp":1763096400000},{"market":"US","date":"2025-11-12","symbol":"MTSR","fiscalQuarterEnding":"2025/09","expectedEps":-0.56,"name":null,"time":"盤後","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-1.11},{"market":"US","date":"2025-07-28","symbol":"MTSR","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1753675200000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2025-05-12","symbol":"MTSR","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-1.03},{"market":"US","date":"2025-03-26","symbol":"MTSR","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1742961600000,"reportTimeType":"pre","actualEps":-3.52}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MTSR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MTSR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1761886800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MTSR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MTSR","date":"2025-11-14","current":-11.964575,"percent":0.036082,"low":-55.8522,"twenty":-17.976689,"median":-12.456963,"eighty":-10.995731,"high":-6.570442,"avg":-14.489177,"sd":5.001483,"marketCap":7429021324},"quantilePoints":[{"date":"2025-02-07","current":-17.973411,"twenty":-17.939327,"median":-17.8882,"eighty":-17.837073,"marketCap":3042628924},{"date":"2025-02-14","current":-18.277736,"twenty":-18.639274,"median":-18.277736,"eighty":-17.958804,"marketCap":3094146515},{"date":"2025-02-21","current":-19.257661,"twenty":-19.263748,"median":-18.612493,"eighty":-17.973411,"marketCap":3260033158},{"date":"2025-02-28","current":-15.222317,"twenty":-19.263748,"median":-18.292952,"eighty":-17.802989,"marketCap":2576909901},{"date":"2025-03-07","current":-16.749262,"twenty":-19.257661,"median":-17.973411,"eighty":-16.634383,"marketCap":2835398748},{"date":"2025-03-14","current":-15.094245,"twenty":-18.72205,"median":-17.767653,"eighty":-15.847091,"marketCap":2555229332},{"date":"2025-03-21","current":-17.309229,"twenty":-18.72205,"median":-17.732316,"eighty":-15.847091,"marketCap":2930192911},{"date":"2025-03-28","current":-15.074845,"twenty":-18.72205,"median":-17.767653,"eighty":-15.847091,"marketCap":3152557072},{"date":"2025-04-04","current":-10.624224,"twenty":-18.709149,"median":-17.433667,"eighty":-15.417782,"marketCap":2221812131},{"date":"2025-04-11","current":-6.570442,"twenty":-18.612493,"median":-16.926585,"eighty":-14.065167,"marketCap":1374056864},{"date":"2025-04-17","current":-8.815846,"twenty":-18.585291,"median":-16.597864,"eighty":-11.231036,"marketCap":1843631343},{"date":"2025-04-25","current":-10.639294,"twenty":-18.362232,"median":-16.039969,"eighty":-10.465489,"marketCap":2224963638},{"date":"2025-05-02","current":-11.734368,"twenty":-18.283822,"median":-15.629326,"eighty":-9.926993,"marketCap":2453973115},{"date":"2025-05-09","current":-12.437626,"twenty":-18.170614,"median":-15.417782,"eighty":-10.4896,"marketCap":2601043422},{"date":"2025-05-16","current":-10.120836,"twenty":-18.143134,"median":-15.084545,"eighty":-9.926993,"marketCap":2690472328},{"date":"2025-05-23","current":-11.083125,"twenty":-18.007321,"median":-13.673351,"eighty":-10.08689,"marketCap":2946282563},{"date":"2025-05-30","current":-10.903313,"twenty":-17.962456,"median":-12.437626,"eighty":-10.237022,"marketCap":2898482293},{"date":"2025-06-06","current":-11.330119,"twenty":-17.863854,"median":-12.078462,"eighty":-10.380871,"marketCap":3011942274},{"date":"2025-06-13","current":-13.665697,"twenty":-17.760585,"median":-12.111113,"eighty":-10.505751,"marketCap":3632820504},{"date":"2025-06-20","current":-10.950736,"twenty":-17.702451,"median":-12.009847,"eighty":-10.478878,"marketCap":2911088957},{"date":"2025-06-27","current":-11.345927,"twenty":-17.568059,"median":-11.719298,"eighty":-10.542899,"marketCap":3016144495},{"date":"2025-07-03","current":-11.638368,"twenty":-17.408779,"median":-11.681839,"eighty":-10.571353,"marketCap":3093885594},{"date":"2025-07-11","current":-14.388896,"twenty":-17.268165,"median":-11.697647,"eighty":-10.619566,"marketCap":3825072138},{"date":"2025-07-18","current":-17.506951,"twenty":-17.303722,"median":-11.789624,"eighty":-10.623027,"marketCap":4653960333},{"date":"2025-07-25","current":-15.67129,"twenty":-17.246135,"median":-12.009847,"eighty":-10.627238,"marketCap":4165977359},{"date":"2025-08-01","current":-11.259046,"twenty":-17.080186,"median":-12.060267,"eighty":-10.669177,"marketCap":3465782198},{"date":"2025-08-08","current":-10.542344,"twenty":-16.963959,"median":-11.907491,"eighty":-10.669177,"marketCap":3245165568},{"date":"2025-08-15","current":-10.340985,"twenty":-16.859629,"median":-11.799396,"eighty":-10.571353,"marketCap":3183182801},{"date":"2025-08-22","current":-11.194202,"twenty":-16.776854,"median":-11.704228,"eighty":-10.619566,"marketCap":3445821646},{"date":"2025-08-29","current":-11.958684,"twenty":-16.726286,"median":-11.700938,"eighty":-10.623027,"marketCap":3681146051},{"date":"2025-09-05","current":-12.385292,"twenty":-16.634383,"median":-11.74414,"eighty":-10.624224,"marketCap":3812465474},{"date":"2025-09-12","current":-12.712928,"twenty":-16.561345,"median":-11.903146,"eighty":-10.627666,"marketCap":3913318790},{"date":"2025-09-19","current":-12.252191,"twenty":-16.438168,"median":-11.874013,"eighty":-10.639294,"marketCap":3771493814},{"date":"2025-09-26","current":-17.959018,"twenty":-16.749262,"median":-11.907491,"eighty":-10.774419,"marketCap":5528180703},{"date":"2025-10-03","current":-17.681988,"twenty":-17.103908,"median":-11.968922,"eighty":-10.788708,"marketCap":5442905015},{"date":"2025-10-10","current":-17.989799,"twenty":-17.506951,"median":-12.044006,"eighty":-10.863794,"marketCap":5537655780},{"date":"2025-10-17","current":-18.078722,"twenty":-17.750391,"median":-12.092917,"eighty":-10.890458,"marketCap":5565028223},{"date":"2025-10-24","current":-18.000059,"twenty":-17.870095,"median":-12.173695,"eighty":-10.903313,"marketCap":5540814139},{"date":"2025-10-31","current":-21.796385,"twenty":-17.928237,"median":-12.282118,"eighty":-10.950736,"marketCap":6709406898},{"date":"2025-11-07","current":-27.891028,"twenty":-17.959018,"median":-12.385292,"eighty":-10.986017,"marketCap":8585472031},{"date":"2025-11-14","current":-24.134147,"twenty":-17.976689,"median":-12.456963,"eighty":-10.995731,"marketCap":7429021324}],"updateTime":1774734224176},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MTSR\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2583555831","title":"輝瑞收購Metsera：交易經過與未來減重市場格局分析","url":"https://stock-news.laohu8.com/highlight/detail?id=2583555831","media":"Med视界","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583555831?lang=zh_tw&edition=fundamental","pubTime":"2025-11-13 12:18","pubTimestamp":1763007538,"startTime":"0","endTime":"0","summary":"Metsera董事会认定：尽管诺和诺德的现金对价更高，但其交易结构面临\"不可接受的高法律和监管风险\"，这成为转向辉瑞的关键原因。辉瑞此次收购Metsera的高估值将进一步激活市场热情，推动减肥药行业进入技术迭代与市场扩张的双重加速期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113130346a49e13eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113130346a49e13eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999011175.SGD","LU1894683348.USD","IE00BLSP4452.SGD","LU1066053197.SGD","MTSR","BK4550","LU0868494617.USD","LU1066051498.USD","IE00BLSP4239.USD","BK4532","BK4534","LU0321505439.SGD","LU0985481810.HKD","BK4581","SGXZ57979304.SGD","BK4588","SG9999013999.USD","LU0289739699.SGD","LU0225771236.USD","SG9999001176.USD","BK4599","IE00B19Z3B42.SGD","BK4007","LU0170899867.USD","BK4568","BK4533","IE00B19Z3581.USD","LU0321505868.SGD","LU1093756325.SGD","LU0154236417.USD","IE00BKVL7J92.USD","NVO","SG9999002232.USD","LU0122379950.USD","IE0002270589.USD","LU0456855351.SGD","LU0234572021.USD","SG9999001176.SGD","BK4592","LU1894683264.USD","LU1057294990.SGD","IE000M9KFDE8.USD","LU0306807586.USD","BK4585","LU1883839398.USD","IE00BBT3K403.USD","LU0058720904.USD","LU1093756168.USD","LU1023059063.AUD","PFE"],"gpt_icon":1},{"id":"2583018302","title":"分析-諾和諾德首席執行官在肥胖症交易中釋放出新的風險偏好信號","url":"https://stock-news.laohu8.com/highlight/detail?id=2583018302","media":"路透中文","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583018302?lang=zh_tw&edition=fundamental","pubTime":"2025-11-13 04:04","pubTimestamp":1762977848,"startTime":"0","endTime":"0","summary":"分析-诺和诺德首席执行官在肥胖症交易中释放出新的风险偏好信号诺和诺德在肥胖症药物市场不敌礼来诺和诺德新任首席执行官推行更积极的收购战略一些分析师和投资者对这一变化表示欢迎Sabrina Valle/Maggie Fick. 诺和诺德没有回应置评请求。11 月 7 日，Metsera 发布新闻稿，宣布已接受辉瑞公司的更优惠报价，并称联邦贸易委员会已与 Metsera 联系，警告其诺和诺德的交易可能会带来反垄断风险。诺和诺德随后退出了竞争。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nL4T3WO1HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306807586.USD","LU2491049909.HKD","LU0061475181.USD","LU0234572021.USD","LU2211815571.USD","BK4007","LU0640476718.USD","LU0471298694.HKD","LU1989771016.USD","IE0002141913.USD","LU2237443465.HKD","LU0225284248.USD","LU0114720955.EUR","LU0466842654.USD","LU1712237335.SGD","LU1066053197.SGD","LU1035775433.USD","LU0238689110.USD","BK4533","LU0096364046.USD","LU2237443895.HKD","BK4581","LU1366192091.USD","LU0170899867.USD","LU0353189763.USD","LU0203201768.USD","IE00BWXC8680.SGD","LU2112291526.USD","LU1127390331.HKD","LU0471298777.SGD","IE00BKDWB100.SGD","LU2552382215.SGD","LU1551013342.USD","LU1720051017.SGD","SG9999011175.SGD","IE00BK4W5L77.USD","LU0198837287.USD","LU0321505439.SGD","BK4599","LU1064131342.USD","IE00B2B36J28.USD","LU1988902786.USD","LU1868836757.USD","SGXZ57979304.SGD","LU1720051108.HKD","LU1883839398.USD","MTSR","LU1232071149.USD"],"gpt_icon":1},{"id":"2582432730","title":"GLP-1「三國殺」開局？輝瑞百億鎖定Metsera，諾和諾德中國出招應戰","url":"https://stock-news.laohu8.com/highlight/detail?id=2582432730","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582432730?lang=zh_tw&edition=fundamental","pubTime":"2025-11-12 18:32","pubTimestamp":1762943522,"startTime":"0","endTime":"0","summary":"在此项调整公布之际，辉瑞以100亿美元锁定临床阶段减肥药“新贵”Metsera的全部股权，值得注意的是，诺和诺德也曾积极参与对Metsera的竞购，但最终选择退出角逐。诺和诺德的“守与攻”2025年以来，诺和诺德中国围绕架构调整动作频频。11月8日，辉瑞已敲定以100亿美元收购减肥药初创公司Metsera，作为其进入减肥药市场的跳板。据悉，辉瑞收购Metsera，意在弥补其在减肥药领域的研发挫败。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112183724a6f444e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112183724a6f444e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BBT3K403.USD","LU0289739699.SGD","SGXZ57979304.SGD","IE00BLSP4239.USD","LU0122379950.USD","LU0985481810.HKD","NVO","IE00B19Z3581.USD","BK4007","BK4592","LU0306806265.USD","SG9999001176.SGD","IE000M9KFDE8.USD","IE00BLSP4452.SGD","BK4588","BK4144","LU1023059063.AUD","MTSR","SG9999003800.SGD","SG9999013999.USD","LU0058720904.USD","LU0225284248.USD","LU0321505868.SGD","LU1883839398.USD","LU1066053197.SGD","BK4590","BK4585","IE00BZ1G4Q59.USD","BK4581","LU1066051498.USD","BK4568","BK4599","BK4139","BK4533","LU1093756168.USD","GLP","IE00BKVL7J92.USD","LU0868494617.USD","LU0225771236.USD","SG9999011175.SGD","SG9999001176.USD","PFE","LU0234572021.USD","IE00B19Z3B42.SGD","LU1093756325.SGD","LU0321505439.SGD","BK4532","LU1894683348.USD","LU0456855351.SGD","LU0306807586.USD"],"gpt_icon":1},{"id":"2582953341","title":"輝瑞三季淨賺49億美元，100億收購Metsera佈局減重市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2582953341","media":"ITBEAR科技资讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582953341?lang=zh_tw&edition=fundamental","pubTime":"2025-11-12 12:03","pubTimestamp":1762920226,"startTime":"0","endTime":"0","summary":"11月18日，辉瑞宣布以100亿美元收购减肥药研发初创企业Metsera，交易方案包括每股65.60美元的初始现金支付，以及最高每股20.65美元的里程碑付款。一方面，价格大幅下调直接压缩利润空间；另一方面，辉瑞通过收购Metsera加速布局减重市场，进一步挤压其市场份额。前三季度累计营收450.22亿美元，同比下滑1.84%，但净利润同比增长23.59%至94.19亿美元。公司表示，成本削减措施有效缓解了销售增长放缓的压力，为收购Metsera提供了资金保障。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112130022a6f38a2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112130022a6f38a2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999001176.USD","LU1023059063.AUD","IE000M9KFDE8.USD","BK4581","LU1057294990.SGD","SG9999002224.SGD","SG9999013999.USD","LU0234572021.USD","BK4585","01276","LU0321505868.SGD","SG9999011175.SGD","01801","BK4588","SG9999003800.SGD","LU0058720904.USD","LU1066051498.USD","LU0225284248.USD","IE00B19Z3B42.SGD","LU1093756168.USD","NVO","IE00BZ1G4Q59.USD","BK4139","LU0306806265.USD","LU1066053197.SGD","SG9999002232.USD","LU1883839398.USD","LU0122379950.USD","MTSR","BK4568","LU0154236417.USD","LU0321505439.SGD","LU0225771236.USD","LU0868494617.USD","SG9999001176.SGD","LU0306807586.USD","LU0456855351.SGD","BK4599","BK4532","IE00BBT3K403.USD","LU1894683348.USD","LU1894683264.USD","IE0002270589.USD","LU0289739699.SGD","LU0985481810.HKD","PFE","BK4007","IE00BLSP4452.SGD","BK4534","IE00B19Z3581.USD","LU0170899867.USD","IE00BKVL7J92.USD"],"gpt_icon":1},{"id":"2582908350","title":"FTC出手，諾和諾德出局：輝瑞100億美元收購Metsera後股價雙雙下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2582908350","media":"MedTrend医趋势","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582908350?lang=zh_tw&edition=fundamental","pubTime":"2025-11-11 17:04","pubTimestamp":1762851892,"startTime":"0","endTime":"0","summary":"路透社消息：11月8日，辉瑞以最高100亿美元的价格击败诺和诺德，成功拿下减肥药新星Metsera。此前，11月5日，FTC向诺和诺德发出警告信，指出其收购方案可能违反《哈特-斯科特-罗迪诺反垄断改进法》，并可能降低Metsera继续开发药物的动力。Metsera随后表示，诺和诺德的方案存在\"不可接受的高法律和监管风险\"。从9月22日宣布初步收购协议至今，辉瑞股价累计下跌约3.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111183002a6f1c972&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111183002a6f1c972&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1066053197.SGD","LU1093756325.SGD","LU1023059063.AUD","LU0058720904.USD","IE000M9KFDE8.USD","LU0306806265.USD","BK4599","MTSR","BK4550","SG9999011175.SGD","PFE","IE0002270589.USD","LU1894683264.USD","LU1093756168.USD","BK4581","IE00BLSP4452.SGD","FTC","BK4139","LU0321505868.SGD","NVO","BK4592","BK4007","BK4532","LU0225771236.USD","SG9999002224.SGD","SG9999002232.USD","IE00BKVL7J92.USD","SG9999003800.SGD","BK4534","LU0456855351.SGD","LU0306807586.USD","LU0289739699.SGD","IE00B19Z3581.USD","LU1066051498.USD","LU0154236417.USD","BK4568","LU0122379950.USD","LU0985481810.HKD","LU0234572021.USD","LU0170899867.USD","LU0868494617.USD","IE00BBT3K403.USD","IE00B19Z3B42.SGD","SG9999001176.SGD","IE00BLSP4239.USD","LU1883839398.USD","BK4585","LU0225284248.USD","BK4588","IE00BZ1G4Q59.USD"],"gpt_icon":1},{"id":"2582387897","title":"三季淨賺49億美元！醫藥巨頭輝瑞，100億美元收購Metsera","url":"https://stock-news.laohu8.com/highlight/detail?id=2582387897","media":"云掌财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582387897?lang=zh_tw&edition=fundamental","pubTime":"2025-11-11 08:38","pubTimestamp":1762821492,"startTime":"0","endTime":"0","summary":"11月18日，有消息称，辉瑞已同意以100亿美元收购减肥药研发初创企业Metsera，此前该公司与诺和诺德就后者展开激烈竞购。Metsera宣布，已与辉瑞达成修订版合并协议，辉瑞将以每股最高86.25美元收购Metsera，其中包括每股65.60美元的初始现金支付，以及达到特定里程碑时最高每股20.65美元的额外付款。加上辉瑞收购Metsera的搅局，诺和诺德未来受到的冲击将更加的明显。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511110838259761498e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511110838259761498e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","SG9999003800.SGD","BK4550","LU1066053197.SGD","LU1066051498.USD","BK4585","SG9999011175.SGD","MTSR","LU0985481810.HKD","LU1093756325.SGD","LU1023059063.AUD","LU0154236417.USD","IE00B19Z3581.USD","LU0456855351.SGD","LU0868494617.USD","BK4007","LU1894683348.USD","LU1894683264.USD","IE000M9KFDE8.USD","PFE","IE0002270589.USD","IE00BZ1G4Q59.USD","LU0306807586.USD","LU0170899867.USD","SG9999002232.USD","BK4581","SG9999002224.SGD","LU0225284248.USD","SG9999001176.SGD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","BK4588","LU1057294990.SGD","BK4592","BK4568","BK4139","LU0225771236.USD","LU0234572021.USD","LU1883839398.USD","LU0321505868.SGD","IE00BBT3K403.USD","LU0321505439.SGD","SG9999001176.USD","LU0306806265.USD","LU1093756168.USD","IE00BLSP4239.USD","SG9999013999.USD","LU0058720904.USD","BK4533","NVO"],"gpt_icon":1},{"id":"2582386646","title":"11月11日隔夜要聞：美股收高 小鵬汽車大漲 蘋果將推遲下一代iPhoneAir 輝瑞贏得Metsera競購戰","url":"https://stock-news.laohu8.com/highlight/detail?id=2582386646","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582386646?lang=zh_tw&edition=fundamental","pubTime":"2025-11-11 06:30","pubTimestamp":1762813800,"startTime":"0","endTime":"0","summary":"欲览更多环球财经资讯，请移步7×24小时实时财经新闻。　　11月11日收盘：美股收高科技股领涨 美国政府有望结束停摆。　　11月11日美股成交额前20：闪迪大涨11.9%创历史新高，年内涨幅已超400%. 　　11月11日热门中概股多数收高 小鹏汽车涨16.24%，蔚来跌2.41%. 　　特朗普支持参议院结束政府关闭的协议。　　美国航司取消逾1600个航班 政府停摆效应进一步显现。　　苹果将推迟发布下一代iPhone Air 股价触及日内低点。　　辉瑞赢得Metsera竞购战 诺和诺德退出","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-11-11/doc-infwyqem4651706.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AAPL","BK4599","BK4588","BK4559","LU1301847155.USD","LU2133065610.SGD","LU2237443465.HKD","BK4598","EVS.SI","LU0061475181.USD","BK4550","IE00B7KXQ091.USD","BK4551","IE00B3S45H60.SGD","LU0708995401.HKD","LU1235294995.USD","LU2286300806.USD","PFE","IE00B19Z3581.USD","LU0726765562.USD","XPEV","SG9999015358.SGD","LU0316494557.USD","LU0788109477.HKD","LU1718418525.SGD","LU0210533765.USD","LU0080751232.USD","LU1496350502.SGD","LU2092627202.USD","LU2125154778.USD","MTSR","SG9999014567.USD","LU0154236417.USD","IE00BJLML261.HKD","LU0234570918.USD","LU2456880835.USD","BK1610","BK1575","LU0724617625.USD","LU1551013342.USD","LU1674673428.USD","LU2236285917.USD","LU2077746001.SGD","09868","LU0820561818.USD","LU1232071149.USD","MACW.SI","LU1674673691.USD","BK4170","LU0942090050.USD"],"gpt_icon":1},{"id":"1122731595","title":"醫療保健市場動態綜述","url":"https://stock-news.laohu8.com/highlight/detail?id=1122731595","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122731595?lang=zh_tw&edition=fundamental","pubTime":"2025-11-11 01:23","pubTimestamp":1762795420,"startTime":"0","endTime":"0","summary":"最新的市场动态涵盖医疗保健领域。于东部时间4:20、12:20和16:50独家发布。辉瑞需要扩大其药物管线，而此次交易表明了其在肥胖治疗市场中获得份额的决心。分析师萨西卡恩·乌德温在一份报告中表示，该医疗保健公司第三季度的收益创下223百万泰铢的纪录，受益于税收优惠和更高的收入。她预计，由于新病床的增加、流感暴发所带来的更多本地患者以及新的国际患者市场，集团的强劲收益势头将在第四季度继续。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2506951958.HKD","LU0577902454.USD","LU0823413587.USD","LU2089284900.SGD","LU0672654166.SGD","IE00BLSP4239.USD","SG9999005177.SGD","SGXZ27511609.SGD","LU0823417653.USD","LU1839390173.USD","LU0315178854.USD","LU0630378429.USD","LU2089283258.USD","LU0314104364.USD","LU1989772923.USD","IE000M9KFDE8.USD","IE00BBT3K403.USD","SG9999001127.SGD","SG9999001226.SGD","SG9999016042.SGD","LU1634259557.SGD","LU1023059063.AUD","LU2111349929.HKD","LU0326948709.USD","LU0865486749.SGD","LU0878005551.USD","SG9999000459.SGD","IE00BGHQDM52.EUR","LU0985481810.HKD","SG9999002224.SGD","LU0557290698.USD","SG9999004220.SGD","BK4504","LU0543330483.HKD","LU0084288322.USD","LU0188438112.USD","LU0882574139.USD","LU0441854154.USD","BK6516","LU1497733631.SGD","BK4516","SG9999013478.USD","SG9999000343.SGD","LU1282649141.HKD","SG9999006266.SGD","LU1130305938.SGD","SG9999011175.SGD","BK6523","LU0192582467.USD","LU1732799900.SGD","PFE","LU1497734951.SGD","LU1057294990.SGD","LU0737861269.HKD","LU0577902611.USD","LU1363072403.SGD","LU1883839398.USD","LU0306807586.USD","LU0795875086.SGD","LU0588545904.SGD","LU1497733557.USD","BK4534","IE00B19Z3581.USD","LU0261947096.USD","LU0762540952.USD","SG9999002406.SGD","LU0289739699.SGD","LU0011963245.USD","LU0058720904.USD","LU0261945553.USD","SG9999001176.SGD","LU0225284248.USD","LU1066051498.USD","SG9999004360.SGD","LU0029875118.USD","LU0955648018.USD","LU0823397285.USD","LU2023251221.USD","BK4581","SG9999013460.SGD","LU0823417737.USD","SG9999002604.SGD","LU0106831901.USD","LU0831103253.SGD","LU1066053197.SGD","LU0061477393.USD","SG9999003826.SGD","LU0675040207.SGD","LU0122379950.USD","IE00BKZH1Z71.USD","LU0225771236.USD","LU0950375773.USD","LU0170899867.USD","LU0831093199.SGD","BK4599","IE0031814969.USD","SG9999008742.SGD","LU1668664300.SGD","LU0267386448.USD","LU1720051108.HKD","SG9999007991.SGD","SG9999014302.SGD","BK4533","SG9999003800.SGD","BK4139","IE0002270589.USD","LU0648948544.HKD","LU0577902298.EUR","LU2506952097.USD","SG9999001176.USD","LU0158827948.USD","LU2238330802.EUR","LU1548497426.USD","LU1770036033.HKD","LU2506952170.USD","LU0955669360.SGD","LU0823397103.USD","LU1244550494.USD","SG9999002562.SGD","LU0048573645.USD","LU0096374516.USD","LU1732800096.USD","LU2347655156.SGD","SG9999002679.SGD","LU0006306889.USD","IE00BKVL7J92.USD","LU0106261372.USD","SG9999000475.SGD","SG9999014484.SGD","LU1162221912.USD","LU0488056044.USD","LU0588545730.USD","LU0878004406.USD","SGXZ57979304.SGD","LU0098860793.USD","LU0441851309.USD","SG9999002620.SGD","LU0898667661.SGD","LU1956131251.USD","LU0823413660.USD","LU0955623706.USD","LU0321505439.SGD","LU0795875169.SGD","LU1211504680.USD","SG9999001846.SGD","LU0128522157.USD","LU0456855351.SGD","LU0158827781.USD","LU0251144936.SGD","BK6112","LU0532188223.SGD","LU0971096721.USD","SGXZ58947870.SGD","LU0251143029.SGD","IE00BZ1G4Q59.USD","LU0048597586.USD","LU0886674414.USD","LU1894683348.USD","BK4007","IE00BVYPNP33.GBP","LU1720051017.SGD","SG9999013353.USD","LU0225283273.USD","LU1282649810.SGD","LU0384037296.USD","LU2133065610.SGD","LU1244550577.SGD","LU0235996351.USD","MTSR","LU1282649067.USD","LU1074936037.SGD","LU1634259391.SGD","IE00BVYPNQ40.USD","IE00B19Z3B42.SGD","LU0577902371.SGD","LU2257852520.SGD","BK4550","LU1989772840.SGD","BK4585","LU2028103732.USD","BK4592","IE00BLSP4452.SGD","LU1504937902.USD","SG9999001135.SGD","SG9999013486.USD","BK4588","LU0882747503.HKD","BK4127","LU0205439572.USD","LU0306806265.USD","SG9999013999.USD","LU0577902538.SGD","LU2271345857.HKD","LU1522347837.USD","LU2506951875.HKD","SG9999014492.USD","LU2357305700.SGD","LU0588545490.SGD","SG9999001903.USD","LU0210637038.USD","LU0912757837.SGD","LU0868494617.USD","LU0345776255.USD","LU0234572021.USD","SGXZ24219693.SGD","SG9999002414.USD","MS","BK4568","LU0873338254.USD","LU0345775950.USD","SG9999002232.USD","LU0321505868.SGD","SGXZ43160589.SGD","LU1244550221.USD","LU1894683264.USD","LU0320765646.SGD","D05.SI","LU0234570918.USD"],"gpt_icon":1},{"id":"2582708318","title":"背景資料-隨着競爭白熱化，減肥藥開發商排隊開發利潤豐厚的市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2582708318","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582708318?lang=zh_tw&edition=fundamental","pubTime":"2025-11-10 22:45","pubTimestamp":1762785907,"startTime":"0","endTime":"0","summary":"背景资料-随着竞争白热化，减肥药开发商排队开发利润丰厚的市场改写第1、2段，增加辉瑞与Metsera的交易；更新礼来、罗氏、Viking的信息；在第6-7段增加Metsera肥胖症候选药物的细节，在第42-43段增加Scholar Rock的细节。辉瑞PFE.N收购生物技术公司Metsera有望加速其重新进入利润丰厚的肥胖症治疗市场，目前该市场由礼来LLY.N和丹麦竞争对手诺和诺德NOVOb.CO主导。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nL4S3WM182:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT","LU0471298694.HKD","IE00B1XK9C88.USD","AMGN","LU0661504455.SGD","LU0109391861.USD","LU2491050071.SGD","02105","LU0345777147.USD","LU0965508806.USD","LU0310799852.SGD","LU1267930730.SGD","LU2491049909.HKD","LU2237443622.USD","MRK","LU2357305700.SGD","LU1280957306.USD","PFE","LU1162221912.USD","VKTX","LU1093756168.USD","03165","LU1941712264.USD","LU0238689110.USD","LU1015430645.USD","SRRK","LU2237443978.SGD","LU1366192091.USD","LU0466842654.USD","LU0545039389.USD","MTSR","LU0171293334.USD","LU1066053197.SGD","GB00BDT5M118.USD","LU0985320562.USD","03692","LU2461242641.AUD","GPCR","LU2089284900.SGD","LU0640476718.USD","LU0203347892.USD","LU0889566641.SGD","OPK","LLY","AZN.UK","LU0128525689.USD","LU0011850046.USD","LU0957799991.USD","LU2491050154.USD","LU0097036916.USD"],"gpt_icon":1},{"id":"2582872084","title":"輝瑞首席執行官：預計公司將為Metsera支付全部或有價值權利款項。","url":"https://stock-news.laohu8.com/highlight/detail?id=2582872084","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582872084?lang=zh_tw&edition=fundamental","pubTime":"2025-11-10 22:21","pubTimestamp":1762784493,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"14a71f61cb92b2ae51e4a7c3aa48f71f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4007","LU0985481810.HKD","SGXZ57979304.SGD","LU1894683264.USD","IE00BLSP4239.USD","PFE","LU1066053197.SGD","BK4599","LU0234572021.USD","SG9999011175.SGD","BK4568","LU0058720904.USD","SG9999013999.USD","BK4550","BK4581","SG9999002232.USD","BK4585","IE0002270589.USD","LU0456855351.SGD","BK4139","BK4592","LU0225284248.USD","SG9999003800.SGD","LU1023059063.AUD","BK4588","LU1066051498.USD","SG9999001176.USD","IE00BLSP4452.SGD","BK4534","LU0321505868.SGD","LU0306806265.USD","BK4533","LU1894683348.USD","IE00B19Z3581.USD","IE00BBT3K403.USD","LU0321505439.SGD","MTSR","LU0170899867.USD","LU0225771236.USD","SG9999001176.SGD","LU1057294990.SGD","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","LU1883839398.USD","SG9999002224.SGD","LU0868494617.USD","LU0122379950.USD","LU0306807586.USD"],"gpt_icon":0},{"id":"1108133087","title":"Metsera Inc. - 在某些情況下公司需支付的終止費用增加至2.65億美元 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1108133087","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108133087?lang=zh_tw&edition=fundamental","pubTime":"2025-11-10 20:55","pubTimestamp":1762779315,"startTime":"0","endTime":"0","summary":"Metsera Inc. - 在某些情况下公司需支付的终止费用增加至2.65亿美元 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU0122379950.USD","LU0306807586.USD","LU0985481810.HKD","IE00B19Z3B42.SGD","LU1066051498.USD","PFE","LU1066053197.SGD","SG9999011175.SGD","SG9999013999.USD","BK4139","IE00BLSP4239.USD","LU1023059063.AUD","BK4568","LU0321505439.SGD","IE00B19Z3581.USD","BK4592","IE0002270589.USD","IE00BLSP4452.SGD","SG9999002224.SGD","SGXZ57979304.SGD","BK4007","SG9999003800.SGD","LU0868494617.USD","LU0170899867.USD","IE00BBT3K403.USD","BK4585","LU1057294990.SGD","LU1894683264.USD","MTSR","LU0289739699.SGD","LU1883839398.USD","LU0225284248.USD","LU0456855351.SGD","SG9999001176.SGD","LU0321505868.SGD","LU1894683348.USD","SG9999002232.USD","BK4581","BK4533","SG9999001176.USD","IE000M9KFDE8.USD","LU0058720904.USD","LU0225771236.USD","BK4588","BK4599","BK4534","LU0306806265.USD","LU0234572021.USD"],"gpt_icon":0},{"id":"2582820050","title":"輝瑞豪擲百億美元拿下Metsera，諾和諾德放棄加碼","url":"https://stock-news.laohu8.com/highlight/detail?id=2582820050","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582820050?lang=zh_tw&edition=fundamental","pubTime":"2025-11-10 19:29","pubTimestamp":1762774140,"startTime":"0","endTime":"0","summary":"辉瑞将以每股最高86.25美元的价格进行收购。","market":"us","thumbnail":"https://static.tigerbbs.com/cf3f1b6f3bdeb24d39a170d440c2bf65","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/cf3f1b6f3bdeb24d39a170d440c2bf65"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1310ced763b367f15a56d0feccf44e16","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1367408.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MTSR","PFE"],"gpt_icon":1},{"id":"2582820431","title":"背景資料-過去十年涉及美國製藥商和生物技術公司的重大交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2582820431","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582820431?lang=zh_tw&edition=fundamental","pubTime":"2025-11-10 19:23","pubTimestamp":1762773795,"startTime":"0","endTime":"0","summary":"在过去十年中，美国制药公司为收购从肿瘤学、神经学到罕见病和肥胖症等领域前景看好的疗法而进行的引人注目的交易越来越多，此举为这一交易添上了浓墨重彩的一笔。根据LSEG编制的数据，截至今年7月9日，全球已签署了价值1053亿美元的制药和生物技术并购交易，比去年同期增长了7%，创下了自2023年以来的最高纪录。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nL4T3WM0SQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1059921491.USD","LU2361044865.SGD","LU2324357040.USD","LU1941712264.USD","MRK","BK4516","LU2237443382.USD","LU1670710661.SGD","LU1670710588.SGD","LU1868836757.USD","LU1023059063.AUD","IE00BKVL7J92.USD","LU2361044949.HKD","IE00B3PB1722.GBP","LU2089283258.USD","LU1196500208.SGD","LU1732800096.USD","BK4578","LU1929549753.HKD","LU1267930573.SGD","LU1699723380.USD","JNJ","PFE","LU1057294990.SGD","LU0708994859.HKD","LU2471134952.CNY","LU2237443465.HKD","LU0203347892.USD","LU1670711123.USD","IE0034235303.USD","LU2468319806.SGD","LU2237443622.USD","VTRS","LU1061106388.HKD","ABBV","IE00B7SZLL34.SGD","LU0985320562.USD","LU2237443549.SGD","SG9999013999.USD","IE0002141913.USD","GILD","LU2361045086.USD","BMY","IE00B42XCP33.USD","MTSR","IE000M9KFDE8.USD","LU0792757196.USD","LU0310800379.SGD","IE00BGHQF631.EUR","IE00B4R5TH58.HKD"],"gpt_icon":1},{"id":"2582822676","title":"BUZZ-輝瑞以 100 億美元收購美特斯邦威，競購戰結束，美特斯邦威暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2582822676","media":"路透中文","labels":["shareholding","corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582822676?lang=zh_tw&edition=fundamental","pubTime":"2025-11-10 18:28","pubTimestamp":1762770503,"startTime":"0","endTime":"0","summary":"11月10日 - ** 上周五晚些时候，一场激烈的制药商竞购战结束，美赛拉MTSR.O股价盘前大跌15.7%，至70.12美元。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nL4T3WM0PB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding,corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU0234572021.USD","BK4568","LU0321505868.SGD","LU0225771236.USD","LU0868494617.USD","BK4550","LU1894683264.USD","BK4534","BK4585","IE00BLSP4239.USD","LU0058720904.USD","BK4139","SG9999003800.SGD","BK4581","LU1894683348.USD","BK4533","SG9999011175.SGD","SGXZ57979304.SGD","BK4592","LU0321505439.SGD","SG9999002232.USD","LU1883839398.USD","LU1057294990.SGD","LU1066053197.SGD","PFE","IE00B19Z3B42.SGD","SG9999013999.USD","IE000M9KFDE8.USD","LU0289739699.SGD","SG9999002224.SGD","LU0306806265.USD","BK4588","IE00BLSP4452.SGD","LU0225284248.USD","IE00B19Z3581.USD","IE0002270589.USD","BK4599","LU0122379950.USD","MTSR","SG9999001176.SGD","SG9999001176.USD","LU1066051498.USD","LU0306807586.USD","LU1023059063.AUD","LU0456855351.SGD","LU0985481810.HKD","IE00BBT3K403.USD","LU0170899867.USD"],"gpt_icon":1},{"id":"2582805690","title":"近期交易合作|藥捷安康臨床前小分子出海，輝瑞截胡諾和諾德收購Metsera","url":"https://stock-news.laohu8.com/highlight/detail?id=2582805690","media":"药菓","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582805690?lang=zh_tw&edition=fundamental","pubTime":"2025-11-10 18:01","pubTimestamp":1762768886,"startTime":"0","endTime":"0","summary":"上海民为生物将取得丹麦Sidera公司9.99%的股权。02贝达药业与晟斯生物达成战略合作11月2日，贝达药业公告称，与晟斯生物达成战略合作。03药捷安康与Neurocrine达成项目合作11月3日，药捷安康与Neurocrine达成项目合作，共同开发NLRP3抑制剂，用于治疗多种疾病。根据协议，Neurocrine获大中华区以外独家开发、制造及商业化NLRP3抑制剂权利，药捷安康则拥有大中华区相应权利。药捷安康将获预付款，及与研发和销售里程碑相关的进一步付款，协议总潜在价值达8.815亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111003303a497b55f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"14a71f61cb92b2ae51e4a7c3aa48f71f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111003303a497b55f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0306806265.USD","LU0154236417.USD","IE0002270589.USD","LU0868494617.USD","NVO","LU0225771236.USD","PFE","BK4534","LU0225284248.USD","LU1093756168.USD","LU0306807586.USD","BK4568","IE00BBT3K403.USD","BK4581","IE00BZ1G4Q59.USD","LU1066053197.SGD","SG9999001176.USD","IE00BLSP4452.SGD","IE000M9KFDE8.USD","LU1066051498.USD","SGXZ57979304.SGD","SG9999013999.USD","BK4139","LU1023059063.AUD","IE00B19Z3581.USD","LU0456855351.SGD","LU1057294990.SGD","BK4533","LU1093756325.SGD","LU0321505439.SGD","MTSR","SG9999002232.USD","LU1883839398.USD","LU0985481810.HKD","BK4599","BK4550","IE00BLSP4239.USD","BK4532","LU1894683264.USD","IE00B19Z3B42.SGD","BK4585","BK4588","LU0122379950.USD","LU0170899867.USD","LU0234572021.USD","SG9999011175.SGD","LU0289739699.SGD","LU0058720904.USD","BK4007","SG9999003800.SGD"],"gpt_icon":1},{"id":"1188578840","title":"Metsera已接受輝瑞100億美元的收購要約","url":"https://stock-news.laohu8.com/highlight/detail?id=1188578840","media":"老虎资讯综合","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188578840?lang=zh_tw&edition=fundamental","pubTime":"2025-11-10 09:59","pubTimestamp":1762739979,"startTime":"0","endTime":"0","summary":"11月10日，美国生物制药企业Metsera夜盘大跌逾16%！当地时间11月7日公告称，已与辉瑞公司达成修订后的合并协议。根据协议，辉瑞将以每股最高86.25美元的价格收购Metsera，其中包含每股65.60美元现金及一项或有价值权（CVR），该权利可使持有人获得每股最高20.65美元的额外现金支付。公告显示，Metsera已接受辉瑞100亿美元的收购要约。","market":"us","thumbnail":"https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"14a71f61cb92b2ae51e4a7c3aa48f71f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Metsera已接受辉瑞100亿美元的收购要约","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTSR","PFE"],"gpt_icon":0},{"id":"2582164378","title":"諾和諾德宣佈不再提高對Metsera的收購報價","url":"https://stock-news.laohu8.com/highlight/detail?id=2582164378","media":"药事纵横","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582164378?lang=zh_tw&edition=fundamental","pubTime":"2025-11-10 06:02","pubTimestamp":1762725753,"startTime":"0","endTime":"0","summary":"此举标志着其对Metsera为期一周的主动竞购进程的终结，也体现了公司对财务纪律和股东价值的一贯承诺。此更新报价再次被Metsera董事会认定为“优越”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110060912a6edb627&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110060912a6edb627&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","IE00BZ1G4Q59.USD","BK4599","NVO","BK4139","BK4532","MTSR","BK4588","LU1093756168.USD","BK4007","IE00BKVL7J92.USD","LU1093756325.SGD","LU0154236417.USD"],"gpt_icon":1},{"id":"2582752899","title":"巨頭加價159%，搶購減肥藥公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2582752899","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582752899?lang=zh_tw&edition=fundamental","pubTime":"2025-11-09 17:19","pubTimestamp":1762679948,"startTime":"0","endTime":"0","summary":"11月8日，辉瑞与Metsera共同宣布签署合并协议修正案，后者董事会重申对这笔交易的全力支持。这一最终报价较9月22日辉瑞首次宣布收购意向前Metsera的收盘价33.32美元，溢价高达159%。此前，10月31日，辉瑞对Metsera以及丹麦制药巨头诺和诺德提起诉讼，称Metsera违反并购协议条款。连续受挫后，收购成为其快速切入减重药市场的必然选择。此次修订后的报价较Metsera 9月停牌前33.32美元的收盘价溢价超159%，较其2025年1月上市时27.8亿美元的市值更是实现数倍增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109172304a6ecb008&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109172304a6ecb008&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BLSP4452.SGD","LU0456855351.SGD","BK4550","LU0225771236.USD","LU0154236417.USD","LU0306806265.USD","IE00BBT3K403.USD","LU0225284248.USD","SGXZ57979304.SGD","BK4599","IE00BKVL7J92.USD","LU0170899867.USD","SG9999011175.SGD","SG9999002232.USD","MTSR","IE00B19Z3581.USD","SG9999003800.SGD","LU0289739699.SGD","LU1093756325.SGD","LU1883839398.USD","LU1093756168.USD","IE00BLSP4239.USD","BK4568","LU1066051498.USD","SG9999001176.SGD","IE00BZ1G4Q59.USD","LU0985481810.HKD","BK4532","BK4585","BK4588","BK4581","LU1057294990.SGD","IE0002270589.USD","LU0058720904.USD","BK4592","SG9999001176.USD","IE00B19Z3B42.SGD","SG9999002224.SGD","LU0122379950.USD","LU1894683264.USD","LU1894683348.USD","BK4139","LU0306807586.USD","IE000M9KFDE8.USD","NVO","BK4534","SG9999013999.USD","LU1023059063.AUD","LU0868494617.USD"],"gpt_icon":1},{"id":"2581852937","title":"Metsera：接受輝瑞100億美元收購要約","url":"https://stock-news.laohu8.com/highlight/detail?id=2581852937","media":"南方财经网","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581852937?lang=zh_tw&edition=fundamental","pubTime":"2025-11-08 16:47","pubTimestamp":1762591638,"startTime":"0","endTime":"0","summary":"南方财经11月8日电，美国生物制药企业Metsera当地时间11月7日公告称，已与辉瑞公司达成修订后的合并协议。根据协议，辉瑞将以每股最高86.25美元的价格收购Metsera，其中包含每股65.60美元现金及一项或有价值权（CVR），该权利可使持有人获得每股最高20.65美元的额外现金支付。公告显示，Metsera已接受辉瑞100亿美元的收购要约。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511083558880477.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4599","IE000M9KFDE8.USD","LU0225771236.USD","SG9999002224.SGD","IE00B19Z3B42.SGD","BK4568","LU0234572021.USD","SG9999013999.USD","IE00BLSP4452.SGD","SG9999011175.SGD","IE00BBT3K403.USD","LU0170899867.USD","LU1883839398.USD","LU0058720904.USD","LU0321505868.SGD","SG9999003800.SGD","SG9999002232.USD","IE00B19Z3581.USD","IE00BLSP4239.USD","SGXZ57979304.SGD","BK4533","SG9999001176.USD","BK4007","BK4550","LU1066051498.USD","LU0306807586.USD","PFE","LU1057294990.SGD","SG9999001176.SGD","LU0456855351.SGD","LU0868494617.USD","LU1894683264.USD","LU0321505439.SGD","LU0122379950.USD","LU0225284248.USD","BK4534","IE0002270589.USD","LU0985481810.HKD","LU1023059063.AUD","BK4588","LU1066053197.SGD","MTSR","BK4592","BK4581","BK4585","LU1894683348.USD","LU0306806265.USD","BK4139","LU0289739699.SGD"],"gpt_icon":0},{"id":"2581852817","title":"諾和諾德：鑑於公司對財務紀律和股東價值的承諾，不會提高收購Metsera的報價。","url":"https://stock-news.laohu8.com/highlight/detail?id=2581852817","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581852817?lang=zh_tw&edition=fundamental","pubTime":"2025-11-08 16:25","pubTimestamp":1762590318,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4532","BK4007","IE00BKVL7J92.USD","BK4585","MTSR","LU1093756168.USD","BK4588","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVO","BK4599","LU0154236417.USD","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":198,"code":"91000000","status":"200"}]}}